Healthcare leaders should not treat planning downtime procedures as a one-and-done project, as industry experts in Las Vegas share.
Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ...
UVA Health CIO flags tech debt and IT restructuring as early priorities to improve clinician workflows and support digital innovation.
Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADE ...
Morning Overview on MSN
Japan approves world-first iPSC therapy for Parkinson’s disease
Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...
An Informational Consumer Analysis of AgelessRx's Prescription Process, NAD+ Therapies, GLP-1 and Compounded Semaglutide Options, Off-Label Longevity Medications, and Cash-Pay Pricing Structure for 20 ...
Abstract: The increasing complexity of patient data and the need for reliable, transparent decision-making in healthcare drive the demand for advanced AI systems. This paper introduces a Clinical ...
Vanish Skincare's nanofiber dry-fiber delivery format, barrier repair ingredient research, and published guarantee conditions examined for consumers researching acne mask options in 2026. Boca Raton, ...
Mount Sinai study multi-agent AI shows higher accuracy and lower computing use managing up to 80 clinical tasks simultaneously in simulations.
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and ...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2025 Earnings Call Transcript March 12, 2026 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.15451 EPS, expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results